Medclair AB (NGM:MCLR)

Medclair AB Statistics

Total Valuation

Medclair AB has a market cap or net worth of SEK 230.98 million. The enterprise value is 229.19 million.

Market Cap	230.98M
Enterprise Value	229.19M

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Medclair AB has 82.49 million shares outstanding. The number of shares has decreased by -19.15% in one year.

Current Share Class	82.49M
Shares Outstanding	82.49M
Shares Change (YoY)	-19.15%
Shares Change (QoQ)	+4.39%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 41.39.

PE Ratio	41.39
Forward PE	n/a
PS Ratio	4.62
PB Ratio	4.13
P/TBV Ratio	10.34
P/FCF Ratio	64.54
P/OCF Ratio	41.13
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.26, with an EV/FCF ratio of 64.04.

EV / Earnings	43.90
EV / Sales	4.58
EV / EBITDA	22.26
EV / EBIT	39.19
EV / FCF	64.04

Financial Position

The company has a current ratio of 3.02

Current Ratio	3.02
Quick Ratio	1.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	1.00

Financial Efficiency

Return on equity (ROE) is 9.80% and return on invested capital (ROIC) is 6.86%.

Return on Equity (ROE)	9.80%
Return on Assets (ROA)	5.89%
Return on Invested Capital (ROIC)	6.86%
Return on Capital Employed (ROCE)	10.47%
Revenue Per Employee	3.57M
Profits Per Employee	372,929
Employee Count	14
Asset Turnover	0.81
Inventory Turnover	1.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +118.18% in the last 52 weeks. The beta is 1.03, so Medclair AB's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	+118.18%
50-Day Moving Average	2.97
200-Day Moving Average	2.25
Relative Strength Index (RSI)	45.93
Average Volume (20 Days)	100,980

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medclair AB had revenue of SEK 50.04 million and earned 5.22 million in profits. Earnings per share was 0.07.

Revenue	50.04M
Gross Profit	35.79M
Operating Income	5.85M
Pretax Income	5.22M
Net Income	5.22M
EBITDA	10.30M
EBIT	5.85M
Earnings Per Share (EPS)	0.07

Balance Sheet

The company has 1.79 million in cash and n/a in debt, giving a net cash position of 1.79 million or 0.02 per share.

Cash & Cash Equivalents	1.79M
Total Debt	n/a
Net Cash	1.79M
Net Cash Per Share	0.02
Equity (Book Value)	55.88M
Book Value Per Share	0.68
Working Capital	16.76M

Cash Flow

In the last 12 months, operating cash flow was 5.62 million and capital expenditures -2.04 million, giving a free cash flow of 3.58 million.

Operating Cash Flow	5.62M
Capital Expenditures	-2.04M
Free Cash Flow	3.58M
FCF Per Share	0.04

Margins

Gross margin is 71.53%, with operating and profit margins of 11.69% and 10.43%.

Gross Margin	71.53%
Operating Margin	11.69%
Pretax Margin	10.43%
Profit Margin	10.43%
EBITDA Margin	20.58%
EBIT Margin	11.69%
FCF Margin	7.15%

Dividends & Yields

Medclair AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	19.15%
Shareholder Yield	19.15%
Earnings Yield	2.26%
FCF Yield	1.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7